Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell

Molecules. 2017 Sep 5;22(9):1477. doi: 10.3390/molecules22091477.

Abstract

Ginger has many bioactive compounds with pharmacological activities. However, few studies are known about these bioactive compounds activity in chemoresistant cells. The aim of the present study was to investigate the anticancer properties of ginger phytochemicals in docetaxel-resistant human prostate cancer cells in vitro. In this study, we isolated 6-gingerol, 10-gingerol, 4-shogaol, 6-shogaol, 10-shogaol, and 6-dehydrogingerdione from ginger. Further, the antiproliferation activity of these compounds was examined in docetaxel-resistant (PC3R) and sensitive (PC3) human prostate cancer cell lines. 6-gingerol, 10-gingerol, 6-shogaol, and 10-shogaol at the concentration of 100 μM significantly inhibited the proliferation in PC3R but 6-gingerol, 6-shogaol, and 10-shogaol displayed similar activity in PC3. The protein expression of multidrug resistance associated protein 1 (MRP1) and glutathione-S-transferase (GSTπ) is higher in PC3R than in PC3. In summary, we isolated the bioactive compounds from ginger. Our results showed that 6-gingerol, 10-gingerol, 6-shogaol, and 10-shogaol inhibit the proliferation of PC3R cells through the downregulation of MRP1 and GSTπ protein expression.

Keywords: drug resistance; ginger; prostate cancer.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Docetaxel
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Male
  • Phytochemicals / chemistry
  • Phytochemicals / pharmacology*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Prostatic Neoplasms / drug therapy*
  • Taxoids / therapeutic use*
  • Zingiber officinale / chemistry*

Substances

  • Antineoplastic Agents
  • Phytochemicals
  • Plant Extracts
  • Taxoids
  • Docetaxel